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Intrathecal morphine (ITM) can protect the heart against ischaemia reperfusion injury (IRI) by activating 
spinal but not peripheral opioid receptors.
1
  This study examined the mechanisms through which this 
protection may be signalled.  An open chest rat model of IRI was used with an indwelling polyethylene 
catheter placed into the subarachnoid space 3 days before experimentation.  Fifteen minutes prior to the 
ITM preconditioning, antagonists were given intravenously to evaluate the role of adenosine, bradykinin, 
calcitonin gene related peptide (CGRP) receptors as well as the autonomic pathway.  Groups of animals 
(n=6/group) were, respectively, given the polar adenosine receptor antagonist 8-(p-sulfophenyl) 
theophylline (8-SPT), the bradykinin B2 antagonist HOE-140, CGRP fragment 8-37, and the nicotinic 
receptor blocker hexamethonium bromide (HEX) in a randomised order.  Intrathecal saline infusion was 
used as control.  The adenosine blocker 8-SPT was also given intrathecally as spinal opioids are known 
to induce local adenosine release.
2
  ITM preconditioning was induced with 3μg/kg morphine immediately 
before 30 minutes of ischaemia in the territory supplied by the left coronary artery and 120 minutes 
reperfusion.  The hearts were then excised and the infarct size as a percentage of the area at risk 
(IS/AAR) was determined by triphenyltetrazolium and Evan Blue staining.  The groups were comparable 
in terms of haemodynamics at baseline and the area at risk.  The IS/AAR in the control group was 57±3% 
compared with 25±5% in the ITM group (P<0.01).  The addition of 8-SPT, HOE-140, CGRP fragment 8-37, 
and HEX intravenously abolished the anti-infarct effect of ITM (41±8%, 52±10%, 56±9%, 51±6%, p<0.01 
respectively compared with ITM).  Interestingly, the intrathecal administration of 8-SPT, which does not 
cross the blood brain barrier, also blocked the effects of ITM (45±7%).  The sole administration of the any 
one of the antagonists did not alter infarct size compared with control.  These results indicate that ITM 
can remotely protect the myocardium through a neural pathway and may involve multiple types of non 
opioid receptor activation.  Spinal adenosine may be involved in the signalling process within the 
intrathecal space.  However, these results do not preclude other mechanisms contributing to the 
preconditioning effect. 
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